Exhibit 5.1
| | | | |
![LOGO](https://capedge.com/proxy/8-K/0001193125-20-121154/g894973g0427213827576.jpg)
| | Dentons US LLP 1221 Avenue of the Americas New York, NY 10020-1089 USA T +1 212 768 6700 F +1 212 768 6800 | | Salans FMC SNR Denton dentons.com |
April 23, 2020
|
iCAD, Inc. 98 Spit Brook Road, Suite 100 Nashua, New Hampshire 03062 |
Re: Sale of Shares of Common Stock registered pursuant to Registration Statement onForm S-3 (FileNo. 333-235887)
Ladies and Gentlemen:
We have acted as counsel to iCAD, Inc., a Delaware corporation (the “Company”), in connection with a registration statement onForm S-3, File No. 333-235887 (the “Registration Statement”), heretofore filed by the Company with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Act”), and the prospectus supplement filed pursuant to Rule 424(b) under the Act, dated as of April 23, 2020 (the “Prospectus Supplement”), under which the Company offered 1,562,500 shares of the Company’s common stock, $0.01 par value per share (the “Shares”). The Shares are being sold pursuant to a securities purchase agreement dated as of April 23, 2020, by and among the Company and the purchasers party thereto (the “Agreement”). Capitalized terms used but not otherwise defined herein shall have the meanings assigned to such terms in the Agreement.
This opinion is being delivered to you pursuant to Item 601(b)(5) ofRegulation S-K under the Act at the request of the Company.
In connection with rendering this opinion, we have examined originals, certified copies or copies otherwise identified as being true copies of the following: (i) the Company’s Certificate of Incorporation, (ii) theCompany’s By-Laws, (iii) the Registration Statement, including the prospectus (the “Base Prospectus”) contained therein, (iv) the Prospectus Supplement (the Prospectus Supplement and the Base Prospectus are collectively referred to herein as the “Prospectus”), (v) corporate proceedings of the Company relating to the Shares, and (vi) such other instruments and documents as we have deemed necessary under the circumstances.
We have assumed the genuineness and authenticity of all documents examined by us and all signatures thereon, and the conformity to originals of all copies of documents examined by us.
Based upon the foregoing, and in reliance thereon, and subject to the qualifications, limitations and exceptions stated herein, we are of the opinion having due regard for such legal considerations as we deemed relevant, that the Shares, have been duly authorized and, when, sold and delivered by the Company against receipt of the purchase price therefor, in the manner contemplated by the Prospectus and the Agreement, will be validly issued, fully paid and nonassessable.
Our opinions are subject to the effect of federal and state bankruptcy, insolvency, reorganization, arrangement, moratorium, fraudulent conveyance and other laws relating to or affecting the rights of secured or unsecured creditors generally (or affecting the rights of only creditors of specific types of debtors), with respect to which we express no opinion.
Lee International● Kensington Swan● Bingham Greenebaum● Cohen & Grigsby● Sayarh & Menjra● Larraín Rencoret● Hamilton Harrison & Mathews● Mardemootoo Balgobin● HPRP● Zain & Co.● Delany Law● Dinner Martin● For more information on the firms that have come together to form Dentons, go to dentons.com/legacyfirms